Please ensure Javascript is enabled for purposes of website accessibility
Jim Halley

Jim Halley


Recent articles

jar full of hundred dollar bills money savings

If You Invested $1,000 in CVS Health During the Last Recession, This Is How Much You Would Have Today

Over the past 11 years, CVS Health has posted a solid return, but was it the best option?

Copy of senior man talking to doctor holding clipboard medical expenses healthcare hospital

3 Cheap Surgical Stocks to Buy Now Before They Bounce Back

The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.

credit card being passed between two hands -- authorized user purchase transaction

3 Stocks You Don't Realize You Use Every Day

These stocks are crucial to everyday life, and that's a great reason to invest in them.

Woman scientist in lab holding up test tube

Is It Too Late to Buy These 3 Pharmaceutical Stocks?

Relmada Therapeutics, Neoleukin Therapeutics, and Durect were among the fastest-rising pharmaceutical stocks over the past year.

exterior of hospital medical healthcare

Trash Is King: 3 Medical Waste Stocks Worth a Look

The surge in COVID-19 cases certainly hasn't hurt the medical waste industry.

income stream cash flow money hundred bills

3 Healthcare Insurance Stocks With Great Dividends and More

Insurance companies know how to play it safe. These three big players in healthcare all offer nice income.

money and pills on scale

Should You Buy These 3 Stocks Tackling Alzheimer's Disease?

Demand for Alzheimer's medication is expected to grow as the population of older adults rises.


3 Pot Stocks Worth a Second Look

These companies are all surprising doubters lately.

dollar bill folded into arrow pointing upward -- high growth stock returns cash money (1)

Is It Time to Cash In on Meridian Bioscience?

Meridian Bioscience has thrived during the COVID-19 pandemic. Can this stock go much higher, or is it time to cash out?

financial health stethoscope money cash hundred bills medical healthcare

3 Big Data Health Stocks to Watch in 2020

Big data is becoming a big factor in the healthcare industry.

doctor talking to senior man -- patient medical medicine healthcare

3 Reasons Jazz Pharmaceuticals Is A Hot Buy Right Now

A new small-cell lung cancer drug approval isn't the only thing the company has going for it.

health monitoring getty

3 Diabetes Monitoring Companies That Are Recession-Proof

As the prevalence of diabetes has grown, these companies are looking for solutions.

bottles of prescription medicine sitting on shelves in cabinet drugs pills

Is GlaxoSmithKline a Great Dividend Stock?

The pharmaceutical giant recently cut its dividend, but it still pays a better yield than most in the industry.

dna genetics science biology (2)

3 Ultra-High-Growth Biopharma Stocks to Grab Now

Can the run for Sarepta Therapeutics, Viela Bio, and Aptose Biosciences continue?

financial health stethoscope money cash hundred bills medical healthcare

Zynex Soared Last Week. But Is It a Risky Buy?

Zynex climbed to record highs on Thursday, but there are reasons to pump the brakes on this medical equipment company.


These 2 Stocks Are Cleaning Up Thanks To Medical Mask Sterilization. Are They Buys?

Steris and Fortive are on the rise, thanks in part to their medical devices used to decontaminate N95 or N95-equivalent respirators.


3 Pot Stocks to Stay Miles Away From

There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.

patient having blood pressure measured by doctor -- healthcare medical cardio stress physical

Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?

The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?

7 glass jars filled with coins -- money savings diversification

4 Hot Dividend Stocks Yielding More Than 6%

They all pay handsomely to income-conscious investors and have sustainable payouts.


Is Cresco Labs a Risky Buy?

The Chicago company's growth may allow it to be a cannabis survivor. Here's what investors need to know.